Phillip A. Swanson

Most-cited papers

1. Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial

   Betty Mwesigwa, Katherine V. Houser, Amelia R Hofstetter, Ana M. Ortega-Villa +47 more

   2023Lancet. Infectious Diseases (Print)22 citations Open access

   Semantic Scholar

   Save

2. OMIP‐067: 28‐Color Flow Cytometry Panel to Evaluate Human T‐Cell Phenotype and Function

   Phillip A. Swanson, Robert A. Seder

   2020Cytometry Part A19 citations Open access

   Semantic Scholar

   Save

3. T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire

   Phillip A. Swanson, M. Padilla, W. Hoyland, K. McGlinchey +61 more

   2021medRxiv18 citations Open access

   Semantic Scholar

   Save

4. Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccine

   Leetah Senkpeil, Jyoti Bhardwaj, Morgan R. Little, P. Holla +30 more

   2021medRxiv12 citations Open access

   Semantic Scholar

   Save

5. Single-cell molecular signature of pathogenic T helper subsets in type 2–associated disorders in humans

   P. Gazzinelli-Guimarães, Brittany Dulek, Phillip A. Swanson, Justin Lack +2 more

   2024JCI Insight8 citations Open access

   Semantic Scholar

   Save

6. Immunogenicity and safety of AZD2816, a beta (B.1.351) variant COVID-19 vaccine, and AZD1222 (ChAdOx1 nCoV-19) as third-dose boosters for previously vaccinated adults: a multicentre, randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study in the UK and Poland.

   M. Ramasamy, Elizabeth J. Kelly, Seth Seegobin, P. Dargan +18 more

   2023The Lancet Microbe4 citations Open access

   Semantic Scholar

   Save